3.31 USD
↘ 0.04 (1.19%)AT CLOSE (03:59 PM EDT)
Tao Synergies Inc. Common Stock
TAOXNASDAQ • USD
3.36
↗ 0.05 (1.39%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
3.36
↗ 0.05 (1.39%)
Market: CLOSED
Tao Synergies Inc. Common Stock (TAOX) trades at $3.31 per share. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. TAOX is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Oct 23, 2026.
Open?$3.36
High?$3.41
Low?$3.30
Prev. Close?$3.35
Volume?55.6K
Avg. Volume?218.2K
VWAP?$3.35
Rel. Volume?0.25x
Bid / Ask
Bid?$2.82 × 100
Ask?$3.78 × 100
Spread?$0.96
Midpoint?$3.30
Valuation & Ratios
Market Cap?26.4M
Shares Out?N/A
Float?7.3M
Float %?97.0%
P/E Ratio?N/A
P/B Ratio?2.07
EPS?-$2.76
Dividend?2.38%
Ex-Dividend?N/A
News
Profile
TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.
Themes
Address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR
NEW YORK, NY 10036
Phone: (973) 242-0005
NEW YORK, NY 10036
Phone: (973) 242-0005
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?50
Momentum?50
Short Sent.?56
Piotroski F-Score?0/9Weak
Confidence?33%Very Low
Short InterestElevated
Short % of Float?9.50%Elevated
Short Interest?689.4K
Days to Cover?2.1
Free Float7.3M
Avg Daily Volume323.6K
Settlement Date2026-09-30
Financial Health
Current Ratio?19.99Strong
Quick Ratio?19.99Strong
Cash Ratio?2.30Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?2.07CHEAP▾
Peers100
S&P73
P/S?34.19HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-3.1CHEAP▾
S&P97
EV/Sales?31.13HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-173.1%WEAK▾
S&P3
ROA?-104.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-6203179
Enterprise Value?$24.0M
Fundamentals ratios updated end of day